Source:http://linkedlifedata.com/resource/pubmed/id/11477446
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2001-7-30
|
pubmed:abstractText |
Previous studies demonstrated that ex vivo IL-2- activated PBSC could generate cytotoxic effectors without impairing haematopoietic reconstitution. Clinical experience and previous studies indicated that children with solid tumours could benefit from high-dose chemotherapy with immune modulation. We studied the generation of cytotoxic effectors from growth-factor +/- chemotherapy-mobilised PBSC from 10 patients (five adults and five children) with different solid tumours. Cells were placed in culture in serum-free culture medium supplemented with IL-2 1000 U/ml +/- IL-12 for 1, 2, 4 or 7 days. Anti-tumour cytotoxicity was tested against K562, Daudi and two neuroblastoma cell lines (Gau, NB91). Cultured adult PBSC in the presence of IL-2 (1000 U/ml) showed marked cytotoxicity against all the cell lines tested from day 1. At day 2, with an E:T ratio of 25:1, cytotoxicity was 53% +/- 10.4, 63.2% +/- 23.8, 38% +/- 9.1, and 39% +/- 15.7 against K562, Daudi, Gau and NB91, respectively. Cytotoxic activity of child PBSC was significantly lower (P < 0.05) and was displayed after longer culture times (day 4). No difference was found in the phenotype analysis of lymphoid subsets before and after IL-2 activation between adult and child PBSC. Haematological properties of the graft were not significantly impaired by IL-2 activation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0268-3369
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
869-75
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11477446-Adult,
pubmed-meshheading:11477446-Age Factors,
pubmed-meshheading:11477446-Blood Cell Count,
pubmed-meshheading:11477446-Blood Cells,
pubmed-meshheading:11477446-Cell Culture Techniques,
pubmed-meshheading:11477446-Child,
pubmed-meshheading:11477446-Cytotoxicity Tests, Immunologic,
pubmed-meshheading:11477446-Hematopoiesis,
pubmed-meshheading:11477446-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:11477446-Humans,
pubmed-meshheading:11477446-Immunophenotyping,
pubmed-meshheading:11477446-Interleukin-12,
pubmed-meshheading:11477446-Interleukin-2,
pubmed-meshheading:11477446-Neoplasms,
pubmed-meshheading:11477446-Stem Cells,
pubmed-meshheading:11477446-Transplantation, Autologous,
pubmed-meshheading:11477446-Tumor Cells, Cultured
|
pubmed:year |
2001
|
pubmed:articleTitle |
In vitro generation of cytotoxic effectors activated by interleukin 2 (IL-2): comparison of autologous peripheral blood stem cells (PBSC) from adults and children.
|
pubmed:affiliation |
Pediatrics Department, Department of Clinical Biology, Institut Gustave Roussy, Villejuif, France.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|